title: Trabectedin is an effective second-line treatment in soft tissue sarcoma patients.
authors.affiliation: Department of Medical Oncology, Centre Oscar Lambret, Lille Medical School of Catholic University, Lille.
authors.forename: C
authors.initials: C
authors.lastname: Peugniez
authors.affiliation: Department of Medical Oncology, Centre Oscar Lambret, Lille.
authors.forename: S
authors.initials: S
authors.lastname: Cousin
authors.affiliation: Department of Medical Oncology, Centre Oscar Lambret, Lille SIRIC OncoLille Consortium, Clinical Research and Methodology Platform, Lille, France n-penel@o-lambret.fr.
authors.forename: N
authors.initials: N
authors.lastname: Penel
mesh_terms: D003606:Dacarbazine / Q000627:therapeutic use; D004149:Dioxoles / Q000627:therapeutic use*; D018572:Disease-Free Survival; D006801:Humans; D012509:Sarcoma / Q000188:drug therapy*; D044005:Tetrahydroisoquinolines / Q000627:therapeutic use*; D000077606:Trabectedin
chemical_list: D004149:Dioxoles; D044005:Tetrahydroisoquinolines; D003606:Dacarbazine; D000077606:Trabectedin